EUVIMEDEUVIMED entdecken
Open Access

Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy

Yongfeng Cheng, Yiping Shen, Yunfei Zhang, Hailiqiguli Nuriding, Xuemei Wang, Chunyan Fan, Gulibaha Maimaiti, Y U Liu, Yingbin Yue, Danlu Li, Mei Yan

Oncology Research · 2025

DOI: 10.32604/or.2025.057842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Yongfeng Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China. Hauptthemen laut MEDLINE: Autophagy, Hodgkin Disease, Antigens, Bacterial. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The growth of the B-cell lymphoma subtype, Hodgkin lymphoma (HL), is associated with increased autophagy. A mycobacterial antigen, Ag85, has been reported to inhibit cell autophagy under a variety of conditions. Whether Ag85 could inhibit autophagy in HL is unknown.

Methods

Lymph node samples from patients with HL and healthy controls were collected to assess proliferation and autophagy. The human HL cell line, L-428, was cultured and subjected to Ag85B treatment. Autophagy in L-428 cells was evaluated through western blotting analysis, immunohistochemistry, and transmission electron microscopy. Apoptosis in these cells was measured using flow cytometry and western blotting. The associated signaling pathways were also analyzed utilizing western blotting. The in vivo impact of Ag85B was studied using BALB/c Nude mice xenografted with L-428 cells.

Results

We observed increased proliferation and autophagy in primary lymphoma tissues of patients. Administration of Ag85B inhibited the proliferation and autophagy of HL cell lines. Moreover, Ag85B promoted apoptotic pathway activation in vitro, which might be associated with mitochondrial dysfunction. Mechanistically, Ag85B inhibits autophagy by activating the phosphatidylinositol-4,5-bisphosphate 3-kinase/protein kinase B/mechanistic target of rapamycin kinase (PI3K/AKT/mTOR) and mitogen-activated protein kinase (MAPK) pathways. Ag85B also inhibited lymphoma growth in mice xenografted with HL cell lines, but no potential toxicity was observed.

Conclusion

Altogether, these results suggest that Ag85B inhibits HL growth via autophagy regulation. Current treatments for HL are associated with adverse events; therefore, Ag85B-mediated autophagy inhibition might be a promising strategy in to treat HL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyHodgkin DiseaseAntigens, BacterialHumansAnimalsMiceCell ProliferationCell Line, TumorApoptosisXenograft Model Antitumor AssaysFemaleMaleMice, Inbred BALB CSignal TransductionMice, Nude

Stichwörter der Autor:innen

AutophagyHodgkin diseaseMitogen-activated protein kinasesMycobacterial antigenProtein kinase B

Substanzen

Antigens, Bacterial

Autor:innen und Institutionen

  • Department of Pediatrics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
  • Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Zitieren

APA

Cheng, Y., Shen, Y., Zhang, Y., Nuriding, H., Wang, X., Fan, C., Maimaiti, G., Liu, Y. U., Yue, Y., Li, D., & Yan, M. (2025). Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy. Oncology Research. https://doi.org/10.32604/or.2025.057842

Vancouver

Cheng Y, Shen Y, Zhang Y, Nuriding H, Wang X, Fan C, et al. Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy. Oncology Research. 2025. doi:10.32604/or.2025.057842

BibTeX
@article{Cheng2025,
  author = {Cheng, Yongfeng and Shen, Yiping and Zhang, Yunfei and Nuriding, Hailiqiguli and Wang, Xuemei and Fan, Chunyan and Maimaiti, Gulibaha and Liu, Y U and Yue, Yingbin and Li, Danlu and Yan, Mei},
  title = {Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2025.057842}
}
Kostenlos starten →